Study details
Enrolling now
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
Columbia University
NCT IDNCT06720545ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 3.1 years
Ages
18+
Locations
1 site in NY
What this study is about
Researchers are testing the effect of stopping neurostimulation therapy on cardiovascular and metabolic health in adults with obstructive sleep apnea. The trial will evaluate if stopping this treatment affects patients' risk of medical problems related to OSA.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use No HGNS therapy (HGNS-off)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.